MedicineAccess
We're building a rare disease company that is deliberate and purposeful in its approach
We are agile and identify new opportunities to broaden patient access to new and existing medicines
We move quickly and cost-effectively to rapidly commercialise products
We are curious and energetic with a problem-solving mindset
We use new ways of working whenever we can to create value and support scale-up
Our Team
An experienced, entrepreneurial team united by a shared mission to make a measurable difference in rare diseases. Meet the board:
Ahmed Al-Derzi
CEO & Co-Founder
Ahmed has over 30 years of experience as an entrepreneur and business leader in generic and speciality medicines.
John Irwin
Chief Commercial Officer & Co-Founder
John has more that 25 years of experience in value creation across orphan medicines and rare disease.
Dr Kieran Rooney
Non-Executive Director
Kieran brings over 30 years of experience in corporate and business development across biopharma, with expertise in rare disease.
Values that shape how we work
Compassion, Respect & Humility
We put patients and people first, listening carefully, acting with empathy, and recognising that meaningful impact starts with respect.
Openness & Diversity of Thought
We value different perspectives and experiences, knowing that better decisions come from open dialogue and inclusive thinking.
Innovation & Challenge
We challenge convention and apply fresh thinking to solve complex problems, always focused on creating practical impact.
Collaboration & Meaningful Work
We work together with purpose, supporting one another to deliver work that matters for patients, healthcare systems and commercial partners.
OTD-NP-GBR-00002 | March 2026